.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CF01_Dicloxacillin.Dicloxacillin .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CF01_Dicloxacillin.Dicloxacillin| name: | Dicloxacillin |
| ATC code: | J01CF01 | route: | oral |
| n-compartments | 1 |
Dicloxacillin is a narrow-spectrum beta-lactam antibiotic of the penicillin class, used primarily to treat infections caused by penicillinase-producing staphylococci. It is active against Gram-positive bacteria and is approved for clinical use in many countries for conditions such as skin and soft tissue infections.
Pharmacokinetic parameters in healthy adult volunteers after single oral dosing.
Bock, M, et al., & Moser, C (2023). Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 77(2) 242–251. DOI:10.1093/cid/ciad168 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36947131
Wu, G, et al., & Shentu, J (2015). Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses. Drug design, development and therapy 9 5687–5695. DOI:10.2147/DDDT.S92117 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26527863
Langtry, HD, & Balfour, JA (1998). Azithromycin. A review of its use in paediatric infectious diseases. Drugs 56(2) 273–297. DOI:10.2165/00003495-199856020-00014 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9711451